Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Bulletin Du Cancer|July 3, 2010
[Antitumor properties of the bisphosphonate zoledronate and potential therapeutic implications in the clinic]P Clézardin
Presse Medicale (Paris, France : 1983)|April 4, 2000
[Bone hyperresorption in bone metastases]P Clézardin
Current Pharmaceutical Design|August 21, 2010
Nitrogen-containing bisphosphonates and cancer immunotherapyP Clézardin, M Massaia
Joint Bone Spine|April 25, 2000
Mechanisms of action of bisphosphonates on tumor cells and prospects for use in the treatment of malignant osteolysisP Clézardin, J Gligorov, P Delmas
Journal of Cellular Biochemistry|October 28, 1999
Decorin inhibits cell migration through a process requiring its glycosaminoglycan side chainB Merle, L Durussel, P D Delmas, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 7, 2000
Platelet-osteosarcoma cell interaction is mediated through a specific fibrinogen-binding sequence located within the N-terminal domain of thrombospondin 1C Voland, C M Serre, P Delmas, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 19, 2019
The RANK-RANKL axis: an opportunity for drug repurposing in cancer?S Peters, P Clézardin, I Márquez-Rodas, et al.
Neoplasia (New York, N.Y.)|September 3, 2025
Contribution of the immune bone marrow microenvironment to tumor growth and bone deconstruction: implications for improving immunotherapeutic strategies in bone metastasisE Massy, C B Confavreux, M Point, et al.
Breast Cancer Research and Treatment|October 10, 2006
Transcriptome analysis reveals an osteoblast-like phenotype for human osteotropic breast cancer cellsA Bellahcène, R Bachelier, C Detry, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 8, 2001
Early detection of bone metastases in a murine model using fluorescent human breast cancer cells: application to the use of the bisphosphonate zoledronic acid in the treatment of osteolytic lesionsO Peyruchaud, B Winding, I Pécheur, et al.
Pageof 2